Release Date: Wednesday, Nov. 11, 2020
Expiration Date: Thursday, Nov. 11, 2021

Educational Overview
Pneumococcal disease is a leading cause of hospitalization and mortality in the United States. The Centers for Disease Control and Prevention (CDC) estimates that 4 million episodes of Streptococcus pneumoniae infections occur each year, including about 900,000 cases of pneumococcal pneumonia resulting in as many as 400,000 hospitalizations. Older adults are particularly vulnerable to pneumococcal disease and its associated complications. Among all those who are hospitalized, the mortality rate ranges from 5%‒7%, with even higher rates among those 65 years and older.


The most effective way to protect against pneumococcal disease is through vaccination. However, in the US, only 56% of non-institutionalized adults ≥65 years of age have been vaccinated. The immunization rate among younger vulnerable adults who are eligible for vaccination, such as immunocompromised individuals, is even lower at less than 20%. The challenge remains in overcoming the many barriers associated with adult vaccination. Part of the challenge is having a thorough understanding of the currently available pneumococcal vaccines and their characteristics, including serotype coverage and immunogenicity among various patient groups. Pharmacists play a significant role in reducing the burden of pneumococcal disease in the community and institutional settings. Therefore, they must be aware of vulnerable patient populations and have a thorough understanding of the latest ACIP immunization recommendations. This program will focus on reviewing the burden of pneumococcal disease in vulnerable adults and offer pharmacists strategies to improve vaccination of at-risk individuals through communication and education techniques.


Target Audience
This continuing pharmacy education activity is planned to meet the needs of pharmacists in a variety of practice settings, including large and small healthcare systems, outpatient clinics, managed care organizations, long-term care facilities, and academia. This program targets pharmacists who are at the forefront of caring for adult patients eligible for immunizations and/or at risk for vaccine-preventable diseases.

Learning Objectives
Upon completing this activity, participants will be able to:

  • Describe the clinical consequences of pneumococcal disease and its associated complications among at-risk adults
  • State the latest ACIP recommendations for pneumococcal vaccination among older adults and other at-risk patient populations
  • Identify strategies to adhere to ACIP pneumococcal vaccination recommendations and overcome barriers by both healthcare providers and patients

Educational Format

This online presentation is developed for pharmacists who are at the forefront of caring for adult patients eligible for immunizations and/or at risk for vaccine-preventable diseases. It discusses the following topics:

  1. Incidence and consequences of pneumococcal disease
  2. Risk factors for infection and serious complications
  3. Updated ACIP recommendations
  4. Tactics to adhere to ACIP recommendations
  5. Communication strategies to overcome patient barriers to vaccination


James S. Lewis II, PharmD, FIDSA

ID Clinical Pharmacy Coordinator
& Adjunct Associate Professor
Oregon Health and Science University
Departments of Pharmacy & Infectious Diseases
Portland, OR





aetghCenter for Independent Healthcare Education is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education. Center has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.
ACPE UAN: 0473-9999-20-008-H06-P
Activity type: Knowledge-based


For questions regarding the accreditation of this activity, please contact us at


Method of Participation and Instruction for Credit

  1. Review the entire CPE information including target audience, learning objectives, and disclosures.
  2. Review the activity in its entirety.
  3. Complete the Online Post Test, Evaluation, and Credit Application form
  4. Please note that to receive credit you must achieve a score of at least 70%.
  5. Credits will be uploaded to CPE Monitor within 4 weeks of activity completion and you will be able to access your credits from the profile you set up with NABP.

Disclosure of Conflicts of Interest

In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME), Center for Independent Healthcare Education requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.

Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.



James S. Lewis, PharmD has relevant financial relationships with commercial interests:
Consultant: Merck & Co., Inc., Entasis, SeLux Diagnostics
Dr. Lewis does not discuss off-label uses of any products.

No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

There is no fee to participate in this activity.

Hardware/Software Requirements
Microsoft Internet Explorer, Mozilla Firefox, Apple Safari or Google Chrome with the QuickTime Plug-in
Note: Please disable any “pop-up blocker” features.

Adobe® Reader version 7 or above to view PDF files (If you do not have Adobe® Reader, you can download it for free from
Adobe Flash Player version 10 or above to view multimedia content (If you do
not have Adobe Flash Player, you can download it for free from

Connection Speed
Cable, DSL, or better of at least 300 kbps

System Check
Please e-mail any questions or concerns to

Copyright Statement
Copyright © 2020 Vemco MedEd. All Rights Reserved. Permission for accreditation use granted to Center for Independent Healthcare Education.

Privacy Policy

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support

This activity is supported by an educational grant from Merck & Co., Inc.




By clicking on the activity icon below, I acknowledge that
I have read the entire CPE information.